National Survey on Hypertension at Hospital (PROPHYL HO)

This study has been completed.
Information provided by:
AstraZeneca Identifier:
First received: June 9, 2008
Last updated: August 4, 2009
Last verified: August 2009

To evaluate (with sufficient accuracy) the profile(demographic and clinical characteristics, health care management) of hypertensive patients seen in hospital out patient's department by a cardiologist or a nephrologists.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Profile of Hypertensive Patients Seen in Hospital Outpatient's Department

Resource links provided by NLM:

Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Demographic, clinical and health care characteristics [ Time Frame: Once ]

Enrollment: 655
Study Start Date: December 2007
Study Completion Date: September 2008


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

First five consecutive patients with hypertension seen by Cardiologists


Inclusion Criteria:

  • Known hypertension
  • agree to take part in this study

Exclusion Criteria:

  • none
  Contacts and Locations
Please refer to this study by its identifier: NCT00695266

  Show 120 Study Locations
Sponsors and Collaborators
  More Information

No publications provided

Responsible Party: Alain Castaigne, Medical Director, AstraZeneca Pharmaceuticals Identifier: NCT00695266     History of Changes
Other Study ID Numbers: NIS-CFR-DUM-2007/5
Study First Received: June 9, 2008
Last Updated: August 4, 2009
Health Authority: France: French Data Protection Authority

Additional relevant MeSH terms:
Vascular Diseases
Cardiovascular Diseases processed this record on April 23, 2014